Acquired activated protein C resistance in myeloma patients with venous thromboembolic events

被引：10

作者：

Deitcher, SR ^{[1
]}

Choueiri, T ^{[1
]}

Srkalovic, G ^{[1
]}

Hussein, MA ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Cleveland, OH 44195 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 123卷 / 05期

关键词：

venous thromboembolism; plasma cell dyscrasia; activated protein C resistance; factor V Leiden;

D O I：

10.1046/j.1365-2141.2003.04720.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：959 / 959

页数：1

共 6 条

[1]

DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P1380

[2]

GOLDENBERG N, 2003, J THROMBOSIS HAEMO S, V1, P838

[3] Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism [J].

Haim, N ;

Lanir, N ;

Hoffman, R ;

Haim, A ;

Tsalik, M ;

Brenner, B .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (02) :91-96

[4] Acquired resistance to activated protein C in breast cancer patients [J].

Nijziel, MR ;

van Oerle, R ;

Christella, M ;

Thomassen, LGD ;

van Pampus, ECM ;

Hamulyák, K ;

Tans, G ;

Rosing, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :117-122

[5]

SARIG G, 2003, J THROMBOSIS HAEMO S, V1, P823

[6] Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications [J].

Zangari, M ;

Saghafifar, F ;

Anaissie, E ;

Badros, A ;

Desikan, R ;

Fassas, A ;

Mehta, P ;

Morris, C ;

Toor, A ;

Whitfield, D ;

Siegel, E ;

Barlogie, B ;

Fink, L ;

Tricot, G .

BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (03) :187-192

← 1 →